Yousry A. Ammar

Madinat An Nasr, C, Egypt

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications

Insights into novel benzo[h]quinoline-based 2-thioxothiazolidin-4-one and thiazol-4-one hybrids as potential antimicrobial, and antibiofilm candidates: Design, synthesis, molecular modeling, and in-silico ADME studies.

Insights into novel benzo[h]quinoline-based 2-thioxothiazolidin-4-one and thiazol-4-one hybrids as potential antimicrobial, and antibiofilm candidates: Design, synthesis, molecular modeling, and in-silico ADME studies.

Journal: Bioorganic chemistry
Published: April 13, 2026

Exploring novel indenoquinoxaline Schiff bases as corrosion inhibitors for conversion coating on mild steel: ultrasonication-assisted synthesis and electrochemical and computational studies.

Exploring novel indenoquinoxaline Schiff bases as corrosion inhibitors for conversion coating on mild steel: ultrasonication-assisted synthesis and electrochemical and computational studies.

Journal: RSC advances
Published: April 06, 2026

Chitosan-quinoxaline Schiff base hydroxyapatite composite with antimicrobial properties for bone regeneration.

Chitosan-quinoxaline Schiff base hydroxyapatite composite with antimicrobial properties for bone regeneration.

Journal: Scientific reports
Published: January 19, 2026

Discovery of New Pyrazole-Linked Pyridine Derivatives as Multi-Target Anti-Inflammatory Agents With Immunomodulatory Potential.

Discovery of New Pyrazole-Linked Pyridine Derivatives as Multi-Target Anti-Inflammatory Agents With Immunomodulatory Potential.

Journal: Drug development research
Published: January 07, 2026

Bridging the gap with amide linkers: rational design, synthesis, and multi-target evaluation of sulfonamide/acetamide-NSAID hybrids as dual COX-2/5-LOX inhibitors.

Bridging the gap with amide linkers: rational design, synthesis, and multi-target evaluation of sulfonamide/acetamide-NSAID hybrids as dual COX-2/5-LOX inhibitors.

Journal: Future medicinal chemistry
Published: January 06, 2026

Amphiphilic cellulose and alginate-functionalized magnetic ZIF-8 nanocomposites for dinitrophenol removal, colorimetric H₂O₂ sensing, and antibacterial applications.

Amphiphilic cellulose and alginate-functionalized magnetic ZIF-8 nanocomposites for dinitrophenol removal, colorimetric H₂O₂ sensing, and antibacterial applications.

Journal: International journal of biological macromolecules
Published: October 16, 2025

Novel niclosamide-derived Schiff bases as a dual-targeted anticancer agents.

Novel niclosamide-derived Schiff bases as a dual-targeted anticancer agents.

Journal: Scientific reports
Published: September 10, 2025

Sustainable novel chitosan sulfonamides conjugated with a phthalazine derivative for enhanced corrosion inhibition in acidic environments.

Sustainable novel chitosan sulfonamides conjugated with a phthalazine derivative for enhanced corrosion inhibition in acidic environments.

Journal: RSC advances
Published: August 29, 2025

Recent advances in adamantane-linked heterocycles: synthesis and biological activity.

Recent advances in adamantane-linked heterocycles: synthesis and biological activity.

Journal: Molecular diversity
Published: July 30, 2025

Development of pyrazole and pyrazolopyrimidine derivatives as promising anti-MRSA agents targeting penicillin-binding protein (PBP2a) and mecA gene.

Development of pyrazole and pyrazolopyrimidine derivatives as promising anti-MRSA agents targeting penicillin-binding protein (PBP2a) and mecA gene.

Journal: Bioorganic chemistry
Published: May 30, 2025

Novel antibacterial, antioxidant, and anti-inflammatory aminated chitosan hybrid quinoline Schiff base as multi-target agent: Design, molecular docking, and toxicity assessment.

Novel antibacterial, antioxidant, and anti-inflammatory aminated chitosan hybrid quinoline Schiff base as multi-target agent: Design, molecular docking, and toxicity assessment.

Journal: Carbohydrate polymers
Published: March 14, 2025

Discovery and optimization of 2-pyridones as dual h-DHFR/EGFRTK inhibitors with immunomodulatory potential; design, synthesis, anti-proliferative activity, and apoptosis inducer.

Discovery and optimization of 2-pyridones as dual h-DHFR/EGFRTK inhibitors with immunomodulatory potential; design, synthesis, anti-proliferative activity, and apoptosis inducer.

Journal: European journal of medicinal chemistry
Published: March 11, 2025
Showing 1-12 of 67

Last Updated: 09/26/2026